Indian companies have made $1.7-billion outbound deals so far this year, against $9.6-billion overseas acquisitions in 2016. But this is set to change as outbound deals worth over $7 billion is in making with a spurt in deals now, especially for assets in Europe. The continent is going through economic stress, as demand has slumped on the back of its ageing population.
While Eicher Motors plans to make about $2-billion bid for motorcycle maker Ducati, Aurobindo Pharma and Intas Pharmaceuticals are in race to buy Teva’s European assets in a deal valued about $1 billion.
Also, Kumar Mangalam Birla-promoted Hindalco